Cannabis Bioscience International Holdings, Inc.
CBIH · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Revenue | $303 | $249 | $317 | $215 |
| % Growth | 21.8% | -21.5% | 47.4% | – |
| Cost of Goods Sold | $40 | $46 | $93 | $47 |
| Gross Profit | $263 | $203 | $223 | $168 |
| % Margin | 86.8% | 81.7% | 70.5% | 78.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $419 | $649 | $1,154 | $0 |
| SG&A Expenses | $419 | $649 | $1,207 | $1,056 |
| Sales & Mktg Exp. | $0 | $0 | $52 | $0 |
| Other Operating Expenses | $265 | $40 | $0 | $0 |
| Operating Expenses | $684 | $689 | $1,207 | $1,056 |
| Operating Income | -$421 | -$486 | -$983 | -$888 |
| % Margin | -139.1% | -195.4% | -310.4% | -413.1% |
| Other Income/Exp. Net | -$127 | -$165 | -$86 | $3 |
| Pre-Tax Income | -$549 | -$651 | -$1,069 | -$885 |
| Tax Expense | $0 | $0 | -$36 | $0 |
| Net Income | -$549 | -$651 | -$1,033 | -$885 |
| % Margin | -181.1% | -261.8% | -325.9% | -411.7% |
| EPS | -0.051 | -0.063 | -0.1 | -0.11 |
| % Growth | 18.9% | 36.9% | 9.1% | – |
| EPS Diluted | -0.051 | -0.063 | -0.1 | -0.11 |
| Weighted Avg Shares Out | 10,716 | 10,318 | 10,020 | 8,091 |
| Weighted Avg Shares Out Dil | 10,716 | 10,318 | 10,020 | 8,091 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $180 | $165 | $91 | $51 |
| Depreciation & Amortization | $33 | -$12 | $36 | $0 |
| EBITDA | -$336 | -$497 | -$905 | -$834 |
| % Margin | -110.7% | -199.8% | -285.7% | -388% |